Hudson Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,741
Closed -$2.13M 66
2021
Q2
$2.13M Buy
8,741
+15
+0.2% +$3.69K 0.88% 36
2021
Q1
$2.17M Buy
8,726
+130
+2% +$31K 0.93% 30
2020
Q4
$1.98M Sell
8,596
-185
-2% -$42.7K 0.88% 33
2020
Q3
$2.23M Sell
8,781
-262
-3% -$64.9K 1.09% 25
2020
Q2
$2.13M Sell
9,043
-386
-4% -$88.1K 1.13% 26
2020
Q1
$1.91M Sell
9,429
-529
-5% -$116K 1.27% 23
2019
Q4
$2.4M Sell
9,958
-262
-3% -$57.8K 1.22% 23
2019
Q3
$1.98M Buy
10,220
+520
+5% +$99.8K 1.1% 25
2019
Q2
$1.79M Buy
9,700
+1,012
+12% +$181K 1.01% 31
2019
Q1
$1.65M Buy
8,688
+496
+6% +$94.7K 1.01% 29
2018
Q4
$1.59M Buy
8,192
+59
+0.7% +$11.5K 1.16% 23
2018
Q3
$1.69M Buy
8,133
+414
+5% +$81.6K 1.28% 20
2018
Q2
$1.43M Buy
7,719
+723
+10% +$128K 0.99% 31
2018
Q1
$1.19M Buy
6,996
+548
+8% +$101K 0.88% 36
2017
Q4
$1.12M Buy
+6,448
New +$1.14M 0.82% 37

Other funds holding AMGN

Hudson Capital Management's AMGN Position: Q3 2021 in Review

Hudson Capital Management sold out of Amgen (AMGN) in Q3 2021, closing a stake of 8,741 shares — an estimated $2.13M sold.

Hudson Capital Management first reported a position in AMGN in Q4 2017 and held it in 15 quarters. The position peaked at $2.4M in Q4 2019. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Hudson Capital Management reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Hudson Capital Management sold 8,741 Amgen shares in Q3 2021, an estimated $2.13M.
  • Hudson Capital Management first reported a position in Amgen in Q4 2017 and held it in 15 quarters.
  • Hudson Capital Management's Amgen position peaked at $2.4M in Q4 2019.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Hudson Capital Management's 13F filing for Q3 2021, filed 21 Oct 2021.